Loading the session
Loading the session
Loading instrument
$19.54
+1.30%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 15:54 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
1 month: −1.8% (SPY −1.6%, XLV +13.5%). 3 months: +3.9% (SPY −0.4%, XLV +15.5%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: MMED, SPY and XLV · as of 4 Nov 2026
The 4 Nov 2026 close of $19.29 was 4.1% below its 50-day average ($20.11).
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
20.7M shares were sold short at the 15 Oct 2026 settlement; covering them would take 1.0 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Price return, split-adjusted
At the 4 Nov 2026 close
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.
October 14, 2026
−8.64%September 1, 2026
+10.66%June 3, 2026
+15.93%